General Information of the Compound
Compound ID
CP0474358
Compound Name
US10047103, 36
    Show/Hide
Synonyms
1478711-48-6
4-(4-(((6-Methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzofuran-4-yl)oxy)methyl)thiazol-2-yl)-N,N-dimethylbenzamide
4-[4-[[6-methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)-1-benzofuran-4-yl]oxymethyl]-1,3-thiazol-2-yl]-N,N-dimethylbenzamide
BDBM176003
BMS-986141
Benzamide, 4-(4-(((6-methoxy-2-(2-methoxyimidazo(2,1-b)-1,3,4-thiadiazol-6-yl)-4-benzofuranyl)oxy)methyl)-2-thiazolyl)-N,N-dimethyl-
CHEMBL3716552
DB14942
SCHEMBL15348940
UDM-003183
UNII-W530IRZ40G
US9688695, 36
W530IRZ40G
    Show/Hide
Structure
Formula
C27H23N5O5S2
Molecular Weight
561.645
Canonical SMILES
COc1nn2cc(nc2s1)-c1cc2c(OCc3csc(n3)-c3ccc(cc3)C(=O)N(C)C)cc(OC)cc2o1
    Show/Hide
InChI
InChI=1S/C27H23N5O5S2/c1-31(2)25(33)16-7-5-15(6-8-16)24-28-17(14-38-24)13-36-21-9-18(34-3)10-22-19(21)11-23(37-22)20-12-32-26(29-20)39-27(30-32)35-4/h5-12,14H,13H2,1-4H3
    Show/Hide
InChIKey
KEEBLYWBELVGPQ-UHFFFAOYSA-N
CAS
1478711-48-6
Physicochemical Property
logP
5.6255
Rotatable Bonds
8
Heavy Atom Count
39
Polar Areas
104.22
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
11
Complexity
39

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 72188743
ChEMBL ID
CHEMBL3716552
DrugBank ID
DB14942
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04808, Proteinase-activated receptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
EC50 = 0.45 nM
   TI
   LI
   LO
   TS
2
IC50 = 0.4 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Kd = 0.086 nM
2 Kd = 0.1 nM
Clinical Information about the Compound
Drug 1 ( BMS-986141 )
Drug Name BMS-986141
Company Bristol-Myers Squibb
Indication
Thrombosis
Phase 2